Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis

S. Vegter, K. Tolley, T. Wilson Waterworth, H. Jones, S. Jones, D. Jewell

Aliment Pharmacol Ther (2013) 38(3): 284-293

View article

Alicaforsen retention enema induces long-term remission in patients with ulcerative colitis

Heetun Z, Gibson D, Keegan D, Byrne K, Mulcahy HE, Cullen G, Doherty G

Irish Soc Gastroenterol Nov 2014

Please contact for a copy

Alicaforsen, ICAM-1 enema as a treatment option when treating distal ulcerative colitis

L.-Å. Bark 1, I. Löfberg 1, B. Håkansson 1, U. Sjöqvist 1, * 1Gastrosektionen, VO Internmedicin, Södersjukhuset, Stockholm, Sverige

Alicaforsen, ICAM-1 enema as a treatment option when treating distal ulcerative colitis

View abstract

Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-Sided Ulcerative Colitis and Ulcerative Proctitis

Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-Sided Ulcerative Colitis and Ulcerative Proctitis

Thomas Greuter, Stephan R. Vavricka, Luc Biedermann, Julia Pilz, Jan Borovicka, Frank Seibold, Bernhard Sauter, Gerhard Rogler

Digestive Diseases (2017) DOI: 10.1159/000484979

View article

Disclaimer

The information in “published papers” is provided by Atlantic Healthcare plc, and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.